Know exactly who you're buying from.

Orbitrex has a near-spotless purity record from seven Finnrick-verified tests: 99.8–99.9% across all results, with no test below 99.8%. Batch-specific COAs are issued, methodology is documented, and a physical address is on file. Contact information is absent, and ownership is not disclosed — two gaps in the accountability profile. The testing evidence is consistent enough that it crosses into a pattern rather than a lucky sample: seven independent tests with a 0.1% variance range is an unusually tight result set. The open items are the company identity gaps. Until contact information and ownership are published, buyers are transacting with a well-tested but partially anonymous operation.

Bulk Peptide Supply is one of the more transparent operations in this space: named ownership, a verified physical address, and seven products covered by Finnrick-verified independent testing. Average purity across those seven tests is 99.4%, with the lowest result a retatrutide batch at 96.8% — the only test below 98%. Two Finnrick labs are used across the catalog. No contact information is published, which is a gap given the otherwise clean identity record. Coverage is thin relative to catalog size — seven independently verified products across a range that runs wider than that. The core testing infrastructure is legitimate and the business accountability markers are in place. The contact information gap and thin coverage are the two areas that need to close before this vendor ranks higher.

Aavant Research posts some of the tightest purity numbers in this database — 99.87% average across seven Finnrick-verified tests, with no result below 99.7%. Two different Finnrick labs are used across the catalog, including multiple tirzepatide and retatrutide runs. Contact information is public. What's missing: no physical address, no ownership disclosure. The testing record alone would place this vendor higher if the business identity were more fully established. The company's principals are unknown. That's a real gap in accountability for a vendor operating in this space. The chemistry is well-documented; the operator is not.